News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

 
• By Marion Webb, Brian Bossetta, and Natasha Barrow

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

"News We're Watching" Feature Image
• Source: Medtech Insight

More from News We're Watching

More from Medtech Insight